{"id":"W2532466048","doi":"10.1200/jco.2012.30.15_suppl.4006","title":"Tivantinib (ARQ 197) versus placebo in patients (Pts) with hepatocellular carcinoma (HCC) who failed one systemic therapy: Results of a randomized controlled phase II trial (RCT).","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"ca_institutions":"Vancouver General Hospital","funders":"","keywords":"Medicine; Internal medicine; Gastroenterology; Sorafenib; Clinical endpoint; Population; Neutropenia; Placebo; Hepatocellular carcinoma; Progression-free survival; Oncology; Randomized controlled trial; Surgery; Chemotherapy; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002179125,0.001277084,0.00235238,0.0003469073,0.0003143675,0.0007772941,0.0004982261,0.001368481,0.006263646],"category_scores_gemma":[0.00208006,0.000604275,0.002022211,0.0004539837,0.0007506426,0.0007495307,0.0003620535,0.001755399,0.0008871002],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006783113,"about_ca_system_score_gemma":0.0008179741,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008503007,"about_ca_topic_score_gemma":0.001726033,"domain_scores_codex":[0.9991488,0.0005597448,0.0000644902,0.0001051075,0.00004094472,0.00008090596],"domain_scores_gemma":[0.9990702,0.0003168813,0.0002728214,0.00006605288,0.0000635534,0.000210432],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9794392,0.003969023,0.0008506803,0.0008727784,0.001542401,0.00003585529,0.0000372948,0.0001694111,0.001868666,0.00004128914,0.0004909129,0.01068246],"study_design_scores_gemma":[0.9323936,0.0639552,0.001923083,0.00003473808,0.0009568983,0.00002894616,0.00001845985,0.0001404459,0.0001651022,0.00004490531,0.0003317461,0.000007008453],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.984362,0.007848959,0.0005305393,0.0008236189,0.0004224651,0.00304239,0.001351506,0.0001002315,0.00151825],"genre_scores_gemma":[0.987444,0.003981585,0.001036683,0.0008258498,0.0003740778,0.003407001,0.00117059,0.00001911693,0.001741187],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006263646,"threshold_uncertainty_score":0.02095395,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1568732221201914,"score_gpt":0.3878814044888726,"score_spread":0.2310081823686813,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}